MedTrace Logo

Use of Reticulocyte Ratio and Neutrophil / Lymphocyte Ratio in the Diagnosis of Ventilator-associated Pneumonia

NCT04620941 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2024-11-06

No results posted yet for this study

Summary

In this study, the utility of changes in the ratio of Ret-He and NLR as an early inflammation marker for VAP will be evaluated.

Conditions

  • Ventilator-associated Pneumonia (VAP)

Interventions

DIAGNOSTIC_TEST

reticulocyte/hemoglobin (Ret-He) ratio

Ret-He values will be studied on the day (1st day), 4th and 7th days of the diagnosis of ventilator-associated pneumonia in patients hospitalized in the intensive care unit.

Sponsors & Collaborators

  • Muğla Sıtkı Koçman University

    lead OTHER

Principal Investigators

  • turhan togan · Mugla Sitki Kocman Universty Department of Infection Disease

  • Canan Gursoy · Mugla Sitki Kocma University Department of Intensive Care

  • Semra Demirbilek · Mugla Sitki Kocman Universty Department of Anesthesia

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-21
Primary Completion
2023-09-21
Completion
2023-12-21

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04620941 on ClinicalTrials.gov